These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25664975)

  • 1. Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys.
    Farias KJ; Machado PR; Muniz JA; Imbeloni AA; da Fonseca BA
    Viral Immunol; 2015 Apr; 28(3):161-9. PubMed ID: 25664975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroquine interferes with dengue-2 virus replication in U937 cells.
    Farias KJ; Machado PR; de Almeida Junior RF; de Aquino AA; da Fonseca BA
    Microbiol Immunol; 2014 Jun; 58(6):318-26. PubMed ID: 24773578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM).
    Pires de Mello CP; Drusano GL; Rodriquez JL; Kaushik A; Brown AN
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29890736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1.
    Chen WC; Tseng CK; Lin CK; Wang SN; Wang WH; Hsu SH; Wu YH; Hung LC; Chen YH; Lee JC
    Virulence; 2018 Jan; 9(1):588-603. PubMed ID: 29338543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue Virus Evolution under a Host-Targeted Antiviral.
    Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
    J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing antiviral compounds in a dengue mouse model.
    Schul W; Yip A; Shi PY
    Methods Mol Biol; 2013; 1030():269-81. PubMed ID: 23821275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and protective efficacy of a psoralen-inactivated dengue-1 virus vaccine candidate in Aotus nancymaae monkeys.
    Maves RC; Oré RM; Porter KR; Kochel TJ
    Vaccine; 2011 Mar; 29(15):2691-6. PubMed ID: 21303709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of geraniin on dengue virus type-2 infected BALB/c mice.
    Abdul Ahmad SA; Palanisamy UD; Khoo JJ; Dhanoa A; Syed Hassan S
    Virol J; 2019 Feb; 16(1):26. PubMed ID: 30813954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
    Laosutthipong C; Kanthong N; Flegel TW
    Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
    Zandi K; Teoh BT; Sam SS; Wong PF; Mustafa MR; Abubakar S
    Virol J; 2011 Dec; 8():560. PubMed ID: 22201648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An iminosugar with potent inhibition of dengue virus infection in vivo.
    Perry ST; Buck MD; Plummer EM; Penmasta RA; Batra H; Stavale EJ; Warfield KL; Dwek RA; Butters TD; Alonzi DS; Lada SM; King K; Klose B; Ramstedt U; Shresta S
    Antiviral Res; 2013 Apr; 98(1):35-43. PubMed ID: 23376501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable susceptibility of the owl monkey (Aotus nancymae) to four serotypes of dengue virus.
    Schiavetta AM; Harre JG; Wagner E; Simmons M; Raviprakash K
    Contemp Top Lab Anim Sci; 2003 Sep; 42(5):12-20. PubMed ID: 14510518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dengue antiviral candidates in vivo in mouse model.
    Watanabe S; Vasudevan SG
    Methods Mol Biol; 2014; 1138():391-400. PubMed ID: 24696350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olive baboons: a non-human primate model for testing dengue virus type 2 replication.
    Valdés I; Gil L; Castro J; Odoyo D; Hitler R; Munene E; Romero Y; Ochola L; Cosme K; Kariuki T; Guillén G; Hermida L
    Int J Infect Dis; 2013 Dec; 17(12):e1176-81. PubMed ID: 24139794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Callithrix penicillata: a feasible experimental model for dengue virus infection.
    Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF
    Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
    Lee JC; Tseng CK; Wu YH; Kaushik-Basu N; Lin CK; Chen WC; Wu HN
    Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
    Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
    Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of dengue virus production and cytokine/chemokine expression by ribavirin and compound A.
    Rattanaburee T; Junking M; Panya A; Sawasdee N; Songprakhon P; Suttitheptumrong A; Limjindaporn T; Haegeman G; Yenchitsomanus PT
    Antiviral Res; 2015 Dec; 124():83-92. PubMed ID: 26542647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing.
    Frias-Staheli N; Dorner M; Marukian S; Billerbeck E; Labitt RN; Rice CM; Ploss A
    J Virol; 2014 Feb; 88(4):2205-18. PubMed ID: 24335303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.